Drugs / Residronate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00687661 Comparator | Oct 2008 → Jun 2013 | chronic kidney disease | Queen's University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Residronate | “Residronate” NCT00687661 ↗ |
| Route | Oral | “35mg given orally once weekly for 24 months” NCT00687661 ↗ |